Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: Comparison with the changes in the expression of plasma miRNAs

Toxicology

Volumn 322, Issue , 2014, Pages 89-98

  Yamaura, Yu ^a   Nakajima, Miki ^a   Tatsumi, Naoyuki ^a   Takagi, Shingo ^a   Fukami, Tatsuki ^a   Tsuneyama, Koichi ^b   Yokoi, Tsuyoshi ^a,c  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Liver injury; MicroRNA; Zonal expression

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MICRORNA; MICRORNA 100; MICRORNA 101B; MICRORNA 122; MICRORNA 125B; MICRORNA 145; MICRORNA 200B; MICRORNA 21; MICRORNA 22; MICRORNA 222; MICRORNA 26A; MICRORNA 28; MICRORNA 30E; MICRORNA 31; MICRORNA 375; MICRORNA 378; MICRORNA 425; MICRORNA 455; MICRORNA 467A; MICRORNA 664; MICRORNA 674; MICRORNA 690; MICRORNA 709; MICRORNA 720; MICRORNA 872; MICRORNA 877; MICRORNA135A; PARACETAMOL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOPATHOLOGY; LASER MICRODISSECTION; LIVER; LIVER CELL; LIVER CELL DAMAGE; LIVER NECROSIS; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

BIOMARKER; LIVER INJURY; MICRORNA; ZONAL EXPRESSION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; LIVER; MALE; MICRODISSECTION; MICRORNAS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84902002874     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2014.05.008     Document Type: Article

References (31)

1. Braeuning A., Ittrich C., Köhle C., Hailfinger S., Bonin M., Buchmann A., Schwarz M. Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS. J. 2006, 273:5051-5061.
2. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., Zaret K.S., Taylor M. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004, 1:103-106.
3. Chim S.S., Shing T.K., Hung E.C., Leung T.Y., Lau T.K., Chiu R.W., Lo Y.M. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 2008, 54:482-490.
4. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13944-13949.
5. Cortez M.A., Calin G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 2009, 9:703-711.
6. Dillhoff M., Wojcik S.E., Bloomston M. MicroRNAs in solid tumors. J. Surg. Res. 2009, 154:349-354.
7. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
8. Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol. Ther. 1992, 53:275-354.
9. Haasch D., Chen Y.W., Reilly R.M., Chiou X.G., Koterski S., Smith M.L., Kroeger P., McWeeny K., Halbert D.N., Mollison K.W., Djuric S.W., Trevillyan J.M. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol. 2002, 217:78-86.
10. Hailfinger S., Jaworski M., Braeuning A., Buchmann A., Schwarz M. Zonal gene expression in murine liver: lessons from tumors. Hepatology 2006, 43:407-414.
11. Hanke M., Hoefig K., Merz H., Feller A.C., Kausch I., Jocham D., Warnecke J.M., Sczakiel G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 2010, 28:655-661.
12. Ikeda S., Kong S.W., Lu J., Bisping E., Zhang H., Allen P.D., Golub T.R., Pieske B., Pu W.T. Altered microRNA expression in human heart disease. Physiol. Genomics 2007, 31:367-373.
13. Jungermann K. Zonation of metabolism and gene expression in liver. Histochem. Cell Biol. 1995, 103:81-91.
14. Kosaka N., Izumi H., Sekine K., Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence 2010, 1. 10.1186/1758-907X-1-7.
15. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
16. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S., Hatton C.S., Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141:672-675.
17. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
18. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10513-10518.
19. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1604-1609.
20. Park N.J., Zhou H., Elashoff D., Henson B.S., Kastratovic D.A., Abemayor E., Wong D.T. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15:5473-5477.
21. Pritchard C.C., Kroh E., Wood B., Arroyo J.D., Dougherty K.J., Miyaji M.M., Tait J.F., Tewari M. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. 2012, 3:492-497.
22. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
23. Schopman N.C., Heynen S., Haasnoot J., Berkhout B. A miRNA-tRNA mix-up: tRNA origin of proposed miRNA. RNA Biol. 2010, 7:573-576.
24. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12481-12486.
25. Takahashi K., Tatsumi N., Fukami T., Yokoi T., Nakajima M. Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab. Pharmacokinet. 2014, in press.
26. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
27. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49:1098-1112.
28. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating miRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4402-4407.
29. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56:1733-1741.
30. Yamaura Y., Nakanjima M., Takagi S., Fukami T., Tsuneyama K., Yokoi T. Plasma microRNA profiles in rat models of hepatocellular injury cholestasis, and steatosis. PLoS ONE 2012, 7:30250.
31. Zhang F., Xu X., Zhou B., He Z., Zhai Q. Gene expression profile change and associated physiological and pathological effects in mouse liver induced by fasting and refeeding. PLoS ONE 2011, 6:27553.